SuperworthBaker Hughes BKR
- Market cap
- $55.5B
- PE
- 18.0×
- 8y median 20.3×
- Forward PE
- 21.0×
- 10y median 26.3×
- Price to sales
- 2.0×
- EV/EBIT
- 19.4×
- Revenue, 12 months
- $27.7B
- +0% on a year ago
- Net margin
- 11.2%
- Free cash flow yield
- 5.6%
Baker Hughes trades at 18.0× trailing earnings, cheaper than 68% of the last ten years. Revenue was $27.7B over the last twelve months, up 0% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $6.6B+24% | $6.8B+16% | $6.4B+12% | $7.1B+13% | $6.9B+4% | $7.4B+8% | $6.4B+0% | $6.9B−3% | $7B+2% | $7.4B+0% | $6.6B+3% | $6.7B−2% | |
| Cost of revenue | $5.3B+25% | $5.4B+18% | $5B+9% | $5.5B+10% | $5.2B−2% | $5.7B+5% | $5B−1% | $5.3B−4% | $5.3B+2% | $5.6B−1% | $5.1B+3% | $5.2B−3% |
| Gross profit | $1.3B+20% | $1.4B+8% | $1.4B+26% | $1.6B+26% | $1.7B+27% | $1.7B+17% | $1.5B+2% | $1.6B−2% | $1.7B+0% | $1.8B+3% | $1.5B+2% | $1.6B−2% |
| R&D | n/a | n/a | $164M | $158M | $158M | $163M | $146M−11% | $161M+2% | $146M−8% | $147M−10% | $133M−9% | $143M−11% |
| SG&A | $627M+1% | $634M−2% | $618M−6% | $643M−8% | $612M−2% | $585M−8% | $577M−7% | $567M−12% | $607M−1% | $636M+9% | $562M−3% | $569M+0% |
| $714M+165% | $651M−2% | $704M+61% | $845M+64% | $930M+30% | $665M+2% | $752M+7% | $887M+5% | $948M+2% | $755M+14% | $772M+3% | $854M−4% | |
| Interest expense | $49M−25% | $45M−30% | $41M−36% | $47M−19% | $55M+12% | $55M+22% | $51M+24% | $54M+15% | $56M+2% | $61M+11% | $86M+69% | $66M+22% |
| Pre-tax income | $759M+427% | $522M+51% | $641M−16% | $824M+34% | $1B+33% | $792M+52% | $561M−13% | $967M+17% | $821M−19% | $528M−33% | $1.3B+127% | $892M−8% |
| $235M+54% | $71M−55% | $178M−1% | $243M+22% | $235M+0% | −$399M | $152M−15% | $256M+5% | $204M−13% | −$359M−10% | $336M+121% | $210M−18% | |
| Net income | $518M | $440M+142% | $455M−21% | $579M+41% | $766M+48% | $1.2B+168% | $402M−12% | $701M+21% | $609M−21% | $876M−26% | $930M+131% | $681M−3% |
| $0.51 | $0.43+139% | $0.45−21% | $0.58+45% | $0.77+51% | $1.18+174% | $0.40−11% | $0.71+22% | $0.61−21% | $0.88−25% | $0.93+133% | $0.68−4% | |
| 1B | n/a | n/a | 998.3M | 994.8M−2% | n/a | n/a | 987.3M−1% | 998.4M+0% | n/a | 1B | 1B+1% |
Gross profit: 40 periods, Q3 FY16 to Q2 FY26: not printed by the filing, worked out from its own lines.
R&D: Q1 FY17: 6 months less the 3 months printed beside them.
Operating income: 8 periods, Q1 FY24 to Q2 FY26: not printed by the filing, worked out from its own lines.
Net income: Q1 FY17: 6 months less the 3 months printed beside them.
EPS, diluted: Q1 FY17: quarter's net income to common over its shares, to the cent. 4 periods, Q4 FY22 to Q4 FY25: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'.
Diluted shares: Q1 FY17: share-days: the 6-month average less the second quarter's. 11 periods, Q1 FY20 to Q2 FY26: not printed by the filing, worked out from its own lines.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $7.7B | $7.7B to $7.8B | $0.61 | $0.55 to $0.67 | 10 |
| Q4 FY26 | $8.3B | $8.3B to $8.4B | $0.70 | $0.66 to $0.78 | 9 |
| Q1 FY27 | $7.6B | $7.5B to $7.7B | $0.63 | $0.61 to $0.64 | 6 |
| Q2 FY27 | $7.9B | $7.7B to $8B | $0.72 | $0.70 to $0.73 | 3 |
| Q3 FY27 | $8.2B | $8B to $8.3B | $0.78 | $0.76 to $0.80 | 3 |
| Q4 FY27 | $8.5B | $8.4B to $8.6B | $0.87 | $0.85 to $0.89 | 6 |
| Q1 FY28 | $8.2B | $8B to $8.3B | $0.78 | $0.76 to $0.79 | 8 |
| Q2 FY28 | $8.4B | $8.2B to $8.5B | $0.88 | $0.86 to $0.90 | 4 |
Peers
Companies in Oil & Gas Equipment & Services nearest Baker Hughes' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BKRBaker Hughes | $55.5B | 18.0× | 20.3× | 21.0× | 2.0× | +0% | 11.2% |
| SLBSlb | $78.7B | 25.6× | 21.4× | 19.0× | 2.2× | +3% | 8.5% |
| HALHalliburton | $29.1B | 18.3× | 17.6× | 13.8× | 1.3× | +1% | 7.2% |
| FTITechnipFMC | $27.4B | 24.3× | 27.0× | 20.5× | 2.6× | +10% | 11.3% |
| NOVNOV | $7B | 76.0× | 15.3× | n/m | 0.8× | −2% | 1.1% |
| WFRDWeatherford International | $6.2B | 17.1× | 16.9× | n/m | 1.3× | −7% | 7.7% |
| Peer median | $27.4B | 24.3× | 17.6× | 19.0× | 1.3× | +1% | 7.7% |
Investors who own it
Investors we follow who held Baker Hughes at the end of Jun 30, 2026, from their 13F filings.
- Reinhart PartnersReinhart Partners0.1% of portfoliotrimmed
More on Baker Hughes
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #4of 26Oilfield services stocks with the highest profit margins
- #3of 17Oilfield services stocks with the lowest PE ratio
- #4of 15Oilfield services stocks with the fastest earnings growth
Its groups
About
- Industry
- Oil & Gas Equipment & Services
- Sector
- Energy
Valuation data, not investment advice. Prices as of .